Madsen Cecilie, Baandrup Louise, Dehlendorff Christian, Kjaer Susanne K
Unit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Acta Obstet Gynecol Scand. 2015 Jan;94(1):86-94. doi: 10.1111/aogs.12516. Epub 2014 Oct 17.
According to the recent theories on the ovarian cancer origin, any protective effect of tubal ligation may vary with histologic subtype of ovarian cancer. Furthermore, bilateral salpingectomy may represent an opportunity for surgical prevention of serous ovarian cancer.
Nationwide register-based case-control study.
Denmark during 1982-2011.
Cases were all Danish women diagnosed with epithelial ovarian cancer (n = 13 241) or borderline ovarian tumor (n = 3605) in the study period. Age-matched female population controls were randomly selected by risk set sampling. We required that cases and controls have no previous cancer and that controls have no previous bilateral oophorectomy.
Conditional logistic regression was used to estimate odds ratios and 95% confidence intervals, adjusting for potential confounders.
Epithelial ovarian cancer and borderline ovarian tumors stratified according to histology.
Tubal ligation reduced overall epithelial ovarian cancer risk (odds ratios 0.87; 95% confidence interval 0.78-0.98). We observed significant risk variation according to histology (p = 0.003) with the strongest risk reductions associated with endometrioid cancer (odds ratios 0.66; 95% confidence interval 0.47-0.93) and epithelial ovarian cancer of "other" histology (odds ratios 0.60; 95% confidence interval 0.43-0.83). Tubal ligation was not associated with risk of borderline ovarian tumors. Finally, bilateral salpingectomy reduced epithelial ovarian cancer risk by 42% (odds ratios 0.58; 95% confidence interval 0.36-0.95).
We confirmed that tubal ligation reduces the risk of epithelial ovarian cancer and particularly endometrioid cancer. To our knowledge, this is the first observational publication to report on salpingectomy and ovarian cancer risk and our promising findings warrant further investigation.
根据近期关于卵巢癌起源的理论,输卵管结扎的任何保护作用可能因卵巢癌的组织学亚型而异。此外,双侧输卵管切除术可能是手术预防浆液性卵巢癌的一个机会。
基于全国登记的病例对照研究。
1982年至2011年期间的丹麦。
病例为研究期间所有被诊断为上皮性卵巢癌(n = 13241)或交界性卵巢肿瘤(n = 3605)的丹麦女性。年龄匹配的女性人群对照通过风险集抽样随机选择。我们要求病例和对照既往无癌症,且对照既往无双侧卵巢切除术。
采用条件逻辑回归估计比值比和95%置信区间,并对潜在混杂因素进行校正。
根据组织学分层的上皮性卵巢癌和交界性卵巢肿瘤。
输卵管结扎降低了上皮性卵巢癌的总体风险(比值比0.87;95%置信区间0.78 - 0.98)。我们观察到根据组织学存在显著的风险差异(p = 0.003),与子宫内膜样癌(比值比0.66;95%置信区间0.47 - 0.93)和“其他”组织学类型的上皮性卵巢癌(比值比0.60;95%置信区间0.43 - 0.83)相关的风险降低最为明显。输卵管结扎与交界性卵巢肿瘤的风险无关。最后,双侧输卵管切除术使上皮性卵巢癌风险降低了42%(比值比0.58;95%置信区间0.36 - 0.95)。
我们证实输卵管结扎可降低上皮性卵巢癌尤其是子宫内膜样癌的风险。据我们所知,这是第一篇报道输卵管切除术与卵巢癌风险的观察性文献,我们有前景的发现值得进一步研究。